Immune to Cancer: The CRI Blog
-
Omar Ghaffar Breaks Golf World Record and Raises Over $20,000 for CRI
Illinois-based Omar Ghaffar loves golf and is passionate about raising awareness and supporting CRI’s mission. In the… -
UV Safety Awareness Month: Why the Future is Bright for Melanoma Immunotherapies
As the summer peaks and people around the U.S. and the world spend more time outside to… -
Immune Cell Triads Unveil a Critical Role in Fighting Solid Tumors
The Cancer Research Institute (CRI) is excited to share the latest study from CRI Lloyd J. Old… -
July is Sarcoma Awareness Month – Here’s What You Need to Know
Sarcomas are a complex type of cancer that can trick the body into thinking the tumor is… -
10 Attractions to Visit in and around Washington, D.C. While Attending CICON24
The eighth annual CRI-ENCI Cancer Immunotherapy Conference (CICON24) kicks off on September 8 in National Harbor, Maryland…. -
FDA approves EPKINLY® for relapsed or refractory follicular lymphoma
June 26, 2024, marked a milestone for patients suffering from follicular lymphoma. The FDA approved Genmab’s epcoritamab-bysp… -
What’s in Your Glass? Weighing the Health Risks of Alcohol Consumption
“Just one for the road.” We’ve all heard or said this at a party. Alcohol is a… -
CRI’s 5th Annual Wear White Luncheon Raises Over $40,000
On Thursday, June 20, 2024, the Cancer Research Institute (CRI) celebrated its fifth annual Wear White Luncheon,…

Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.